Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Sarcopenia 1Obesity 1Lung Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Early Intervention, Educational 7Methods 6Practice Guidelines as Topic 5Standard of Care 4Educational Status 4Counseling 4Radiotherapy 3Neoadjuvant Therapy 3Magnetic Resonance Spectroscopy 3Biopsy 3Behavior Therapy 3Therapeutics 2Tamoxifen 2Surveys and Questionnaires 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Psychiatric Rehabilitation 2Interviews as Topic 2Chemotherapy, Adjuvant 2Brachytherapy 2Zolpidem 1Yoga 1Venlafaxine Hydrochloride 1Telemedicine 1Specimen Handling 1Soybean Proteins 1Sentinel Lymph Node Biopsy 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Carcinoma In Situ × Soybean Proteins × Clear all
NCT01219075 2023-11-18

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

University of Southern California

Phase NA Completed
110 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡